The binding of unconjugated bilirubin b> serum albumin has received considerable uttention, in large part due to its clinical significance (l-9). Free bilirubin cm produce brain stem damage (kernicterus) in the susceptible brain of t,he newborn, possibly as t,he result of its action as a mitochondrial toxin (9-U).
Such action is not observed in the presence of albumin-bound bilirubin (9, 12, 13) . Furthermore, it has been suggested tBhat the presence in plasma of certain small organic molecules, such as salicylate, sulfonamides, or fatt,y acid, which can displace bilirubin from albumin (4-S, 14, lci) may elevate free bilirubin concentrations to dangerous levels in pathological states involving high plasma bilirubin concent,rntions.
The det,erminat,ion of bilirubin-albunlin binding data is difficult due to the inst,ability and aggregation of free bilirubin in aqueous solution at pllysiological pH values. The methods which have been wed to investigat,e this problem have included absorption spectropliotomet8ry (4-0, lB-IS), ultracent,rifugation (S, 17), ultrafiltration (4, T), equilibrium dialysis (4, IS), elect,rophorcsis (G, 17, ZO), gel filtration (7, 21, 22 ) and, recently, optical rotnt ory dispersion (23) and some contradictory data have bern rcportcd. The invest~igations involving salicylate (4, ci, 1G) or fatty acid (15, 16 ) have most'ly relied on changes in absorption spect,ra as indications of changes in bilirubin binding (alt~liough some semi(lu:rrit,itativc data hnvc been obt,ained by use of some of ttw otllr'r methods listed abovc), ad thrl efficaq-of these small molwules in removing bilirubin from albumin is uncertain.
In the present, investigat~ion it was decided 197 19s WOOLLEY AND HUNTER to determine the extent. of bilirubin-binding by both human and bovine albumin in the presence and absence of varying salicylabe or oleatr coneenkations by use of an ult,racentrifugal t,echnique and to semiquantitatively corroborate t'he ultracentrifugal data by eiectrophoretic analyses. Free bilirubin is optically inactive (S), but large extrinsic Cotton effects in the region of the bilirubin absorption maximum have been observed on the addition of bilirubin to BSA (23)." Exhrinsic Cotton effects of this type have given much valuable information on the binding of various small chromophores by optically active macromolecules (23-30) since the specka we very sensitive to the eI~vironrnet~t at ihe binding site. It thus appeared that this type of analysis was capable of demonst,rating subtle changes in the binding of bilirubin by albumin aft,er the addition of salicylate or oleate which might not' be detected by other metl~ods. Circular dichroism and absorption spectral analyses were t,herefore performed in parallel with the ultracentrifugal analyses.
MATERIALS AND METHODS
Fisher Certified bilirubin it-s.~o,,, = 59,OCU-F2,OOO in chloroform) was obt#ained from Fisher Scient,ific Company. Analysis of standard solutions of t,wo lots of this bilirubin gave molar absorbances of between 59,000 and 60,~. All other chemicals were reagent grade. Bovine plasma Fraction V (Lot No. C34301) was obtained from Armour Pharmaceutical
Company, and a reworked human plasma Fraction V was obt,ained from theMichigan Department of Health, Division of Laboratories, Lansing, Mich., through the courtesy of Dr. James Sgouris. The Fraction \' preparations were obtained in preference to crystalline albumin preparat,ions since the latter generafly contain deeanol which might alter t,he binding characteristics of the albumin and which is dificult to remove from the protein.
H~lrnan and bovine albumin preparations were obtained from the Fraction y powders by exhaustive dialysis of 87, solutions against dist,illed water followed by passage of the dialyzed solutions through mixed-bed deionizing columns (31) t,o remove most of the globulins present in the Fraction \' preparations. The deionized solutions were --2 Abbreviations used are: HSA, human serum albumin; BSA, bovine serum albumin; CD, circular dichroism; ORD, optical rotastory dispersion. ~~illipore-filtered, freeze-dried, and the dry powders stored at 2'. Electrophoretic analysis of the albumins gave only one band on Sepraphore III strips. Ultracentrifugal analysis showed bot,h human and bovine preparations to contain about 5% dimer. The fatty acid content of the BSA was 0.4 moles/mole while that of the HSA was 1.1 moles/mole as determined by the method of Dole (32).
The protein concentration of the stock albumin solutions was determined by absorbance measurements using the following previously determined absorbances (E &. 279 mr): HSA, 5.34; BSA, 6.67. The molecular weight of albumin was taken as 66,ooo.
Protein determinations on the bilirubin-albumin solutions were performed using the biruet reagent (33). Salicylate, present in many of the solutions, interfered wit,h this technique and was removed by precipitating and twice rewashing the protein with 3% trichloroacetic acid. The final precipitate was redissolved in 1.5 ml water, mixed with 4.5 ml biuret reagent, and the absorbance of the resultant solution measured after 20 min against a reagent blank at 550 mp in a Coleman spectrophotometer.
Bilirubin determinations were carried out by the method of Jendrassik and Grof as modified by Gambino (34). However, since salicylate also reacted with the diazo reagent, it was necessary to increase the sodium nitrite concentration to 5.0 g/ 100 ml and add 2 ml of this solution to the sulfanilic acid solution. The salicylate react,ion product had an absorption maximum at 450 rnp but even in high concentration exhibited negligible absorption above 580 rnp. Since the biiirubin reaction product was read at its absorption maximum of 600 rnp, the presence of even large excesses of salicylate did not interfere with t.he estimation of bilirubin concent,ration. For uniformity, this modification was adopted in all bilirubin determinations including t,hose on the standard solutions.
Fatty arid-free TTSA was prepared by the charcoal defatting method of Chen (35). Colloidal charcoal remaining in t,he protein solution at the end of the procedure was removed by passing the solution down a short DEAE-Sephadex A-50 column, 0.2 M phosphate buffer, pH 7.0 at 2". The result.ing preparation contained < 0.01 moles fatty acid/mole IISA.
Stock albumin solut,ions were prepared by dissolving the albumin powders in 0.1 M phosphate buffer, pII 7.40, det,ermining the albumin concentrations by absorbance measurements at 279 rnp, and sdjusting the volume of the albumin solutiun wit.h buffer such that the fmal albumin concentrittion was 68.4 p~ (0.451 g/100 ml). An equimolsr bilirubin solution was prepared by dissolving 4 concentrxtions bet wccn 4 and S moles Jmole bilirubin-ulbumitI I here \vas :t marked increase in the size of the hilirubin pello[3 2s t~lte 01&e eotlcentP>~t ion increased. The sm:l!l but positive bilirubin values which v,we obtained in thtl prwence of an S-fold or grcnt,er csce~s of oleatc were probably due to inaccuracies in the bilirubin :msa~-;11 ~,hese low bilirubin Icvels and to the presence of t r:tccs of ~in~ediil~el~ted frw bilirubin in the ultr:lcentrifuged solutions. In all other inst:uxes tluplic:~t c bilirubin :md pro1 rin det crmin:U ions agreed to w4t,hin 2 7;.
Tlw effect of salicylalc on t)he binding of bilirubin bv albumin in the presence and ;~bww 0; low ole:~ c ~orlce~~tr~~t,~~~Il~ is sllown in Iq'igs. 2and3. Tl~eeffect of salicylat~e NW much less marked t 11an that of' oleat,e, :mtf :I slox bu: steads 10s~ of bilirLlbiI1 was obwr\cb:l :\:i the ssiicylat e concentration inerc~:~sc:c!. The loss of USA-bound biiirubin ( Fig. 3 ) was somewhat great.er than that, of HSA-bound bi!irubin (Fig. a) , especially at> the louver ;I;slicylate concent rations. The adtlit,ion of low ~once~~t,r~t.iotls of &ate to the s:tlicylat,e-biiirubin-albumin solut,ions 1~1 little effect on the extent of bilirubin bindil~~ ~lt~~o~~~l~ the dat.lz obtained wit 11 HSA did show some increase in the loss of bilirubin following the addition of oleate.
~l~~~~~~~,~r~~~~ stu&Ies. Protein and bilirubin determinations were not, performed on the electrophoresed bilirubin-albumin solut iota. The bilirubin and protein bands were esGm:~ted visually before and after staining with amide black 1OB. I'ree bilirubin did ttot migrate in the electric field :tt pH 7.4 :tnd could be observed as a yellon-band at I IIC origin. I~ound bilirubin migrat cd \vit h tlrr albumin t,o t,he anode :IS a yello~v band \vhich bwumc blue after staining n-it 11 the amid0 black. The 1: 1 bilirubin-:rlbumin sohttiotts and t hosc~ \vlticlt contained less than :I .5 :\I ~wxss of olent e sho\ved no yellow band at tl~e origin and :t sl rang yellow bilirubin-:tlbutnin band. As the oleutc concent r:ttion \V:LS incrensed above 5 moles/mole bilirubinP :~lbumin, bilirubin could be seen at tire origin in increasing amounts while the yellow color associated \vit It the albumin brand decreased \\-ith itictwrsing oleal e concentration. When :ttt %!I-fold excess of oleate n-as present, no JY~IIOW color could be discerned at the posit ion of the albumin band. ~~%~I~ elcctropltoresis was performed on solui ion:: which contained salic\-lut e, :t gradual increase in (lte intensity (;f t ltr bilirubin band :rt the origin w: w observed as t,lte sa,licyl:tte conmbnl rat ion was increnscd.
Since it has been shown ihat the optical itroper't ies of bilirttbi~~~~lbltrnir~ solutions c:tn depend on the order of mking tlte COIIstit uents, on the nature and concentration of' the added electrolyte, and on the pH (23)) it should be reemphasized here tlt:l1 all 111~ data reported in this section of the paper \wre obtained by mixing 0.1 II, pH 7.4. pltosphut e buffer solutions of the bilirubin and :dbumin, adding oleatc or salicylat P \vhett required, and allo\ving the soltttions to st :md for -1-12 Itr in the dark before use. The p1-I of the final solutions was 7.30 * 0.05. A i'r\v absorption and CD spectra were obt:Cncd on solutions in which most of the pliosph:~le had been repl:~ced by SaC'l. Tl~c spectra \\we indistingruishablr from tltose obtairtcd t\-ith phosphate alone.
Ak~rp~Gvz spectra.
The spectra of bilirrtbirlPHSA and bilirubirlPRSA solutions in the presence of 0..5-4.0 moles bilirubitl/molr albumin showed a steady increase in the intensity of the absorbance at 450P3B0 rnp :ts the bilirubin concentration increased. This red shift. in tlte \v:~velength of the bilirubin absorption maximum (free bilirubin has an absorption maximum at 33;5-440 mk) ~vas most pronounced at the lower bilirubin concr~titr~~tiottr L 4 and w:ts :tccomp:mied by :t distinct shoulder to 1 he absorption cur\w in the 420-~430 mp wgioti of 111~ spectra.
The the addition of mitochondria or mitochondrial lipid to bilirubin.
Spectral measurements were also conducted on some 1: 1 bilirubin-albumin solutions to which both oleate and salicylate had been added. At low oleate concentrations (below 4 moles oleat'e/mole bilirubin-albumin) the spectra were composites of those obtained with oleate or salicylate alone. At higher oleate concentrations the effect of the oleate almost' completely overwhelmed that of the salicylate except' at very high salkylate concentrations (above 500 moles salicylate/ mole bilirubin-albumin).
The effect of salicylate on the oleate-bilirubin-HSA solutions was somewhat less pronounced than that observed with the bovine protein.
Circular dichroism.
Free bilirubin exhibits no circular dichroism in either aqueous3 or chloroform solution. At the concentrations studied, the albumin solutions displayed no circular dichroism at wavelengths above 300 rnp and showed only a shoulder between 250 and 300 rnp before the st'rong absorption at lower wavelengths. The CD spectra of bilirubin-HSA and bilirubin-BSA in the presence of various amounts of bilirubin are shown in Figs. 6 and 7. Both proteins gave biphasic spectra in the region bekeen 300 and 500 mp. As the bilirubin concentration increased, the spectra obt,ained with the HSA showed a steady increase in the intensity of a positive Cotton effect at about, 460 rnp and a negative Cot,ton effect at about, 410 rnp and had a crossover point at 431 rnp. The spectra obtained with BSA were more complex. At bilirubin concentrations up to 1 mole/mole BSA there was a steady increase in the intensity of t,wo CD bands at 472 and 416 rnp as the bilirubin concentration increased. Above equimolar bilirbuin concentrations t,he two bands decreased in intensity and eventually changed sign such bhat in the presence of a 4 AI excess of bilirubin t,he spectra showed a small positive band at 473 rnp and a somewhat stronger negative band at 392 rnp.
Replicate measurements on 34.2 ~31 1: 1 bilirubin-HSA solutions gave a circular dichroic absorption coefficient (AQ, 456,,J of 37 Z!Z 1. The coefficient obtained with the BSA solutions (AcAr, J,~~,,,) was 72 f 1, approximately twice that of the human protein. Blauer and King (23) have reported the wavelength of the inflection point of the ORD Cotton effect to be 472 rnp, a wavelength identical to that observed for the minimum of the major bilirubin-BSA CD band. This wavelength identity is in sharp contrast to the comparable absorption spectra maxima which were at 471-472 (Blauer and King) and 460 rnp (this paper). These differing results could be due to differing ionic strength (Blauer and King's studies were conducted in approximately 1 ml1 NaCl) or to the use of differing protein preparations. In this regard, one experiment was performed in which crystalline BSA (Armour Pharmaceutical Co., Lot No. E71.503) which contained decanol and 0.66 moles fatty acid/mole BSA was substituted for the BSA prepared from Fraction V. The CD spectra of this 1: 1 bilirubkBSA preparation showed a similar CD band at 472 rnp but no CD band at 416 mp.
The CD spectra were obtained after the addition of salicylate to the 1: 1 bilirubk albumin solutions. Progressive addition of sulicylate to the 1: 1 bilirubin-HSA resulted in a progressive decrease in the intensity of both CD bands although the trough at 403 rnp n-as more affected by low salicylate concentrations than n-as the peak at 456 mp. The changes produced in the bilirubin-BSA spectra were greater and more complex (Fig. S) . Relatively low concentrations of salicylate (11 moles/mole bilirubin-BSA) reduced the magnitude of the trough at 472 rnk to about half of its original value and almost complet8ely extinguished the smaller peak at 416 mp.
The addition of oleate to 1: 1 bilirubin-HSA (Fig. 9 ) produced a steady, marked decrease in the magnitude of the peak at 456 rnk with increasing oleate concentration. The trough at 405 rnp, however, did not decrease in intensity until 3 moles oleate,/ mole bilirubiIIPHSA had been added to t,he solution. When a ii-or G-fold excess of oleate was present, the spectra changed in character and new CD bands of low inter&J were observed. Spectra obtained after the Hrmxtin and E:van's blurb, both of b\-hicll arc tightly bound by albumin (37), were added to BSA solutions in equimolnr amounts in pH 7.4 0.1 11 phosphate buffer. So extrinsic C&ton effects were observed with either solution nor did the addition of equimolar amounts of thew compounds to 1: 1 bilirubin-BSA alt,er the CD spectrum of that complex. Rosenfeld and Snrgenor (37) huvc reported that' the add&ion of bilirubin did not affect the binding of hematin bv albumin and have suggest'ed that the biiirubin and hematin binding sites are different and independent of one another, a situation which wmld be in accord with the CD data.
Since the HSA preparation contained over 1 mole fatty acid/mole HSA, it was decided to defat the protein and examine the CD spectra of the defatted BSA after the addition of equimolar amounts of bilirubin. The spectra obtained with the 1: 1 bilirubindefatted HSA solutions in t#he presence and absence of low oleate concentrations were very similar to those obtained with t,he undefnt,ted protein although some enhancement in the intensity of the CD band at 4% rnp was observed in the absence of oleate.
DISCUSSION
The instability, aggregation, and insolubility of free bilirubin in aqueous solution at physiological pH values presents serious technical problems in investigations involving this compound. While various and sometimes contradictory values have been reported for the solubilit? of bilirubin, the most complete investigation of this problem is that of Burnstine and Schmid (3). They found the solubility of bilirubin in 0.1 M phosphate, pH 7.4, to be about. 7 mg,'lOO ml. However, interpolation of their data to pH 7.4 ionic strength 0.1 phosphate buffer gives a bilirubin solubility t#hat is about 30 times greater than the value of 0.1 mg,/lOO ml r+ ported by Lwtin (IS) at the same pH :md ionic strength. Equilibrium dialysis (4) and ultrafiltration (4, 7) data involvirlg bilirubin concentrations of I mgjlO0 ml or greater have been reported, but we were unable t,o even approach equilibrium bilirubin concentrations on dialysis in cellulose dialysis tubing of 34.2 ~L.\I (2 mg/lOO ml) bilirubin solutions in 0.1 11 phosphate, pH 7.4. l~urthermore, ultrafiltration of the bilirubin solut'ion through :L Diaflo 1'WlO membranr (exclusion mol \vt approx. 10,000) resulted in :f filtrate \vhicll cont:tinrcl only traces 01 bilirubin.
Of the other metllods availablt~ for determining the extent of bilirubin binding b> albumin [gel filt8ration (T, 31, 22)> electroplioredis ((i, 17, 20) 1 tlw peroxidase metlwd of Jacobsen (SO), :urd ultr:~centrifIlgatiorl (S, 17)] the last named WE deemed most, suitnblc for large numbers of samples. It, also had t,he advantage tllat it did not subject tilt: solutions to liglit or t,o large volumes 0i oxygen-contuiliitig sol\-etit,s or solid matricw which could promote oxitlat'ion of' tlw bilirubin. There was somt: concern about t811c long period of t#ime required for the &la-crntrifugat,ion, but preliminary investigat,iona on the absorpt8ion and CD spectra of t'he 1: 1 bilirubin-:llbumirl sohltions befow and after centrifugatioll showed the complcs to be stable under t8hrse conditions. ,1 furthw problem could be encountered in the bilirubin-albumin solutions which contwinc(1 oleate or sulicylate and free bilirubin. Since all but traces (< a(,,) of the free bilirubin sedimented t#o t,llc bottom of the cwtrifugC~ tube where it packed as a pellet, true ttquilibrinm between albumin-bound bilirltbin antI free bilirubin was not achieved. This col~ld introduce an error into tllc correlat!ion of spectral and ultracentrifugal d&r if the presence of the oleate or salicylntc reduwtl the association constant of the bilirubin fog t'he nlbumin to a sufficiently low value resulting in liberation of bound bilirubin during centrifugation. However, the loss of t'lie extrinsic Cotton effects in the CD spectr:L at the same olcnte coticcntrntions as tlwsc wllich result~etl in loss of bilirubin binding as detwmined by the ultracentrfuge t~xpwi-mcnt8s (%Y mole3 olcnt,e,/mole bilirubitlalbumin) would indicate that the binding data represent reasonabl!-:accu&e estimnt,cs of t,he extent of bilirubin binding at the major bilirubin binding sites on the albumin. Furthermore the elcctroplwrctic data provide some corroborat8ive widence for tlre validiby of t'he ult8racentrifugal data although hew again bhe bilirubit-albumin was rcmoved from t'hc free bilirubin during electroplioresis.
Recent data obtained by Jacobsen (39) have shown that the major bilirubin binding sites on HSA are of two classes, the first containing a single site at which bilirubin is bound with a dissociation constant of 7 X 10dg M at pH 7.4 in 0.1 11 Tris-HCl buffer and the second containing two sites with corresponding constants of 2 X 1OW M. Thus in a 1: 1 bilirubin-HSA solution, the bilirubin binding should occur almost entirely at the primary binding site, and the simplifying assumption can be made that the entire Cotton effect arises from the stereospecific binding of a single bilirubin molecule at a single asymmetric locus on the HSA molecule.
Similar binding data are not available for BS,4; however, the ORD titration data of Blauer and King (23) have indicated the presence of one primary bilirubin binding site on BSA with an association constant of 5.7 X lo6 111-l at pH 5. Data obtained at pH 7.4 indicated that' the association constant at, this pH was at least one order of magnitude greater than that determined at pH 5. The existence of one primary bilirubin binding site on BSA is also suggested by the CD spectra obtained in the presence of various bilirubin concentrations as shown in Fig. 7 . Progressive addition of bilirubin to BSA up to equimolar bilirubin concentrations produced a steady increase in the intensity of both Cotton effect CD bands as would be expected for the purely additive effect of saturating a single site. As the bilirubin concentration was raised above the 1: 1 molar ratio, the CD spectra changed in character as if secondary binding sites producing different Cotton effects mere now binding bilirubin. Furthermore, the association constant of the BSA primary bilirubin binding site must be greater than lo7 a+ in pH 7.4, 0.1 M phosphate buffer since less than 5 % of t#he bilirubin was not albumin-bound after ultracentrifugation of the 34.2 ,utir 1: 1 bilirubin-albumin solutions.
The molar amplitudes of the major 1: 1 bilirubin-albumin CD bands are high. The hr. 472 mll of the 1: 1 bilirubin-BSA is 72, greater than the values reported by Schechter (30) for the covalent binding of 2,7-dibromo-4-hydroxy mercurifluorescein to the sulfhydryl group of BSA (Ae,, , 540 ,,,c = 13 at pH 5 and 5 at pH 7) and the noncovalent binding of equimolar amounts of pyridoxal phosphate to BSA (AC,,, 335 ,np = slightly over 4) and is the same order of magnitude as those reported for the major CD bands of various species of cytochrome c at about 400 rnp (40). While both 1: 1 bilirubinalbumin complexes are very similar in their behavior, the spectral data provide striking evidence for the nonidentity of the primary bilirubin binding sites on the two proteins. Although the magnitudes of the molar absorbances at the absorption maxima are quite similar, t,he magnitude of the major BSA CD absorption maximum is about twice that of the HSA. Furthermore although the wavelength of maximun absorption is the same for both the absorption and CD spectra in the case of the HSA, the major CD band observed with the bovine protein has a maximum at a wavelength 12 rnp longer than that observed in the absorbance measurements.
Blauer and King (23) have interpreted the large Cotton effect which they obtained with bilirubin-BSA at pH 5 as being associated with a high degree of inherent dissymmetry and dipole-dipole coupling in the bound bilirubin molecule and have proposed that the bilirubin bound to BSA prossesses the sense of a right-handed helix. They have also suggested that a less dissymmetric conformation with a reduced degree of dipoledipole coupling between the chromophores of the two bilirubin halves exists at more alkaline pH values. Some such couplet could be largely responsible for the Cotton effects observed with the bilirubin-HSA at pH 7.4 (41) where the symmetry of the two CD bands is most pronounced. The complexity of the bilirubin-BSA spectra would suggest that it is a composite of several different types of interaction and that any unique description of the configuration of bilirubin bound to BSA will require further information on the nature of the various transitions which contribute to the Cotton effects. While very little information is available on the bilirubin and albumin groups which are necessary for bilirubin-albumin association, two relevant facts have been published: (1) guanidination of the lysyl residues of HSA results in greatly decreased binding of bili-rubin (18) and, (2) the methyl ester of bilirubin is bound by albumin as strongly as is bilirubin (42, 43).
While no oleate or salicylnte binding measurements were performed on the bilirubin-albumin solutions which contained these anions, previously reported data on the binding of oleate by BSA (44) (46) have reported an association constant of about 2 X lo4 for the first salicylate binding site on BSA at pH 7.4 and weaker binding at five other binding sites, and a survey of the available data on HSA would suggest that a similar situation exists in the human protein. Even at low salicylate concentrations appreciable amounts of free salicylate will be present in the salicylate-containing solutions.
Various mechanisms can be considered for the alterations in the CD spectra following the addition of oleate or snlicylate. It is apparent that the spectra do not reflect t'lle simple loss of bound bilirubin with no change in the manner of binding of the bilirubin which remained bound to the albumin. Some dislocation or translocation of the bound bilirubin or change in the conformation of the albumin must have occurred. Since t'he lack of information on the conformation of albumin in the presence of salicylate and the extensive loss of bilirubin at the higher oleate concentrations make any interpretation of the relevant CD data extremely tenuous, we shall restrict, any further discussion of this topic to the CD spectra which were obtained in the presence of low oleate concentrations, conditions under which 110 bilirubin was liberated from the albumin.
The CD spectral changes which were observed under these conditions could result from (1) binding of oleate at sites distant from the bilirubin binding site with the production of overall conformational changes in the albumin, (2) displacement of the bilirubin to secondary binding sites, or (3) binding of oleate at, or close to, the bilirubin binding site with some perturbation of that site.
(1) Chen (35) has reported that the ORD of HSA (0.74 moles fatty acid/mole HSA) at pH 7.0 remained unchanged after the protein had been defatted (0.01 moles fatty acid/mole HSA). Zakrzewski and Goch (47) have observed changes in the optical activity of HSA at pH 7.0 following the addition of up to 10 moles dodecanoate/mole HSA. They calculated the MofEt-Tang parameters a,, and b. and found that the ORD changes were reflected only in the a0 parameter; b. remained constant throughout the investigated range of binding ratios. It would therefore appear that although the addition of fatty acid can perturb residues at certain loci on the albumin molecule [t'he a,bsorption (47) and fluorescence (48) spect,ral changes that have been observed after the addition of fatty acid offer further evidence of this perturbation], the overall structural conformation of the albumin remains unchanged after the addition of fatty acid at pH 7.0 Furthermore, though not absolutely conclusive, the data of Blaucr and Ring (23) would suggest that no overall conformational changes in the USA occur on the addition of bilirubin to BSA at neutral pH values. The changes in the CD spectra &ich were observed on the addition of low oleate concentrations to the 1: 1 bilirubin-albumin solutions are thus unlikely to be due to overall conformational changes induced by the oleate binding at loci far removed from and independent of the bilirubin binding site.
(2) Since the association constants of the primary bilirubin-HSA site (1.3 X lo8 XI-~) and the bilirubirlPHSA site (> 107 11-l) are much the same or somewhat greater than those of the respective primary oleate binding sites and since several primary oleate binding sites are available for oleate binding, one \vould not expect the addition of 1 or 2 moles of oleate/molc bilirubin-albumin to result in any considrrsble displacement of the bilirubin from its primary binding site.
(3) With the information at present available, it would appear that, the absorption and CD spectral changes could best be 20s WOOLLEY ANI) HUNTEIZ explained in terms of oleate-bilirubinalbumin int,eraction at tlw bihrubin binding site Tvith some result~ant perturbation of the sit'e.
T<ernict'erus, the deposition of UJICOIIjugated bilirubin in the central nervous system, is a disease of the newborn which wpecially threatens premature babies and infants with icterus gravis. While a large percentage of newborns have serum bilirubin Icvels (10 mg/lOO ml or more) higher than that8 of the normal adult (1.0 mg/lOO ml), most clinicians agree that the critical serum limit for the occurrence of kernicterus is :ibout 20 mg/lOO ml, and most kcrnicterus cases have bilirubin concentrations higher t,han this. Most of this excess bilirubin is present in the unconjugated form. Studies on jaundiced patients have shown that almost :dl the bilirubin is bound to albumin (4, 6, 15) and a serum bilirubin concentration of 20 mg/lOO ml (0.342 mli) will result in a bilirubin: albumin molar ratio of about 0.7.
High serum free (i.e., nonesterfied) fatty acid levels (0.5-2.0 mar) are characteristic of newborns (49) and essentially all this fatty acid is bound to albumin giving rise to bound f:tt,ty acid: albumin molar ratios of between 1 and 4. The free fatty acid level rises mark edly following starvation and any such increase in the f&y acid level is generally paralleled by a decrease in the serum bilirubin level (15, 50) . Furthermore, in vitro studies OII kernicterus sera and bilirubinalbumin solutions (16, 51) have shown that t#he addition of oleate will liberate bilirubin from the albumin.
The binding and CD data described in this leaper demonstrate that oleate and bilirubin compete for the primary bilirubin binding site on albumin. While it is hazardous to extrapolate in vitro data to the situation iu P~UO, the binding data do indicate that any increase in the fatty acid:albumin ratio above 4 would result in a considerable loss of serum bilirubin to the intracellular fluid and thus aggravate the disease. The data would also suggest that, at high fatty acid levels, serum bilirubin values may underestimatfl t,he severity of the disease.
The normal therapeutic serum level of salicylate is about 2 mzI resulting in salicg1ate:albumin molar ratios of about 4. The studies of S&mid et al. (*X2) on hyperbilirubinemic rats and of Watson (6) 011 human subjects have shown a marked decrease in the serum bilirubin levels following the infusion or ingestion of salicylate, and various ijl Ldi.0 invest,igatioris (4, 6, 16) have also indicated the loss of albumin-bound bilirubin in the presence of salicylnte. The binding data presented in t'his paper show only a slight decrease in the albumin-bound bilirubin 011 the addit'ion of :L 4 M excess of salicylate, in marked contrast to the large decrease in serum bilirubin observed iu ko. The in viuo data cannot be directly explained in terms of the i/l rlifw binding data. A similar discrepancy has been reported by Ode11 et al. (16). These authors observed that, at bilirubin:albumin molar ratios less than 1, the sera of jnundiccd patients showed significant displacement of bilirubin on addition of saliq-late whereas comparable bilirub&HSA solutions showed little, if :~l>-, displacement of bilirubin from the albumin. 
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